Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
October 25, 1989
Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation
V J Palombella, J Vilcek
Immunology Series
|
January 1, 1992
TNF as a growth factor
J Vilcek, V J Palombella
Molecular and Cellular Biology
|
August 1, 1992
Inducible processing of interferon regulatory factor-2
V J Palombella, T Maniatis
Journal of Cellular Physiology
|
April 1, 1988
Mitogenic action of tumor necrosis factor in human fibroblasts: interaction with epidermal growth factor and platelet-derived growth factor
V J Palombella, J Mendelsohn, J Vilcek
Investigational New Drugs
|
June 17, 2000
Proteasome inhibition: a new strategy in cancer treatment
J Adams, V J Palombella, P J Elliott
Cell
|
September 9, 1994
The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
V J Palombella, O J Rando, A L Goldberg, et al.
Journal of Cellular Physiology. Supplement
|
January 1, 1987
Tumor necrosis factor: receptor binding and mitogenic action in fibroblasts
J Vilcek, M Tsujimoto, V J Palombella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
The proteasome inhibitor PS-341 in cancer therapy
B A Teicher, G Ara, R Herbst, et al.
The Journal of Biological Chemistry
|
February 15, 1987
Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts
V J Palombella, D J Yamashiro, F R Maxfield, et al.
Genes & Development
|
July 1, 1995
Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway
Z Chen, J Hagler, V J Palombella, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
October 25, 1989
Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation
V J Palombella, J Vilcek
Immunology Series
|
January 1, 1992
TNF as a growth factor
J Vilcek, V J Palombella
Molecular and Cellular Biology
|
August 1, 1992
Inducible processing of interferon regulatory factor-2
V J Palombella, T Maniatis
Journal of Cellular Physiology
|
April 1, 1988
Mitogenic action of tumor necrosis factor in human fibroblasts: interaction with epidermal growth factor and platelet-derived growth factor
V J Palombella, J Mendelsohn, J Vilcek
Investigational New Drugs
|
June 17, 2000
Proteasome inhibition: a new strategy in cancer treatment
J Adams, V J Palombella, P J Elliott
Cell
|
September 9, 1994
The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
V J Palombella, O J Rando, A L Goldberg, et al.
Journal of Cellular Physiology. Supplement
|
January 1, 1987
Tumor necrosis factor: receptor binding and mitogenic action in fibroblasts
J Vilcek, M Tsujimoto, V J Palombella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
The proteasome inhibitor PS-341 in cancer therapy
B A Teicher, G Ara, R Herbst, et al.
The Journal of Biological Chemistry
|
February 15, 1987
Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts
V J Palombella, D J Yamashiro, F R Maxfield, et al.
Genes & Development
|
July 1, 1995
Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway
Z Chen, J Hagler, V J Palombella, et al.
Page
of 3